Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape Por Ignacio Monedero-Recuero, Medea Gegia, Douglas Fraser Wares, Sarabjit S. Chadha, Fuad Mirzayev

Obter o texto integral

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis. Por Aastha Gupta, Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Saurabh Rane, Fuad Mirzayev, Matteo Zignol

Obter o texto integral

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis Por Aastha Gupta, Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Saurabh Rane, Fuad Mirzayev, Matteo Zignol

Obter o texto integral

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis Por Jonathon R. Campbell, Dennis Falzon, Fuad Mirzayev, Ernesto Jaramillo, Giovanni Battista Migliori, Carole D. Mitnick, Norbert Ndjeka, Dick Menzies

Obter o texto integral

Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysisResearch in context Por Ioana D. Olaru, Mina Beliz Meier, Fuad Mirzayev, Nevena Prodanovic, Philip J. Kitchen, Samuel G. Schumacher, Claudia M. Denkinger

Obter o texto integral

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007 Por Kristina Wallengren, Fabio Scano, Paul Nunn, Bruce Margot, Sandile S.S. Buthelezi, Brian Williams, Alexander Pym, Elisabeth Y. Samuel, Fuad Mirzayev, Wilfred Nkhoma, Lindiwe Mvusi, Yogan Pillay

Obter o texto integral

Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis Por Nicolas A. Menzies, Brian W. Allwood, Anna S. Dean, Pete J. Dodd, Rein M. G. J. Houben, Lyndon P. James, Gwenan M. Knight, Jamilah Meghji, Linh N. Nguyen, Andrea Rachow, Samuel G. Schumacher, Fuad Mirzayev, Ted Cohen

Obter o texto integral